MAP2K2 (mitogen-activated protein kinase kinase 2)
|
Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
5605 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
Mitogen-activated protein kinase kinase 2 |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
MAP2K2 |
SynonymsGene synonyms aliases
|
CFC4, MAPKK2, MEK2, MKK2, PRKMK2 |
ChromosomeChromosome number
|
19 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
19p13.3 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, cognitive disability, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene. [provided by RefSeq, Jul 2008] |
SNPsSNP information provided by dbSNP.
|
SNP ID |
Visualize variation |
Clinical significance |
Consequence |
rs117945277 |
G>A,C |
Likely-benign, conflicting-interpretations-of-pathogenicity, uncertain-significance |
Coding sequence variant, genic downstream transcript variant, missense variant |
rs121434497 |
A>C,T |
Pathogenic, uncertain-significance |
Coding sequence variant, missense variant |
rs121434498 |
A>C,G,T |
Uncertain-significance, pathogenic, likely-pathogenic |
Coding sequence variant, missense variant |
rs121434499 |
A>G |
Pathogenic-likely-pathogenic, pathogenic, likely-pathogenic |
Coding sequence variant, missense variant |
rs139404261 |
G>A |
Likely-benign, conflicting-interpretations-of-pathogenicity, benign |
Synonymous variant, coding sequence variant |
rs267607230 |
G>A,C,T |
Pathogenic, uncertain-significance |
Missense variant, coding sequence variant |
rs387906800 |
C>T |
Likely-pathogenic, pathogenic |
Coding sequence variant, missense variant |
rs539611844 |
G>A,T |
Conflicting-interpretations-of-pathogenicity |
Intron variant |
rs727504370 |
T>C |
Likely-pathogenic, pathogenic |
Coding sequence variant, missense variant |
rs727504382 |
C>T |
Likely-pathogenic, pathogenic |
Coding sequence variant, missense variant |
rs727504836 |
G>A |
Conflicting-interpretations-of-pathogenicity, likely-benign |
Intron variant |
rs730880511 |
C>A,T |
Likely-pathogenic, uncertain-significance |
Coding sequence variant, missense variant |
rs730880517 |
T>C |
Likely-pathogenic, pathogenic |
Coding sequence variant, missense variant |
rs730880518 |
C>A |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs730880522 |
C>T |
Likely-pathogenic |
Downstream transcript variant, genic downstream transcript variant, missense variant, coding sequence variant, intron variant |
rs759061964 |
T>C |
Conflicting-interpretations-of-pathogenicity, likely-benign |
Coding sequence variant, missense variant |
rs763424788 |
G>A |
Conflicting-interpretations-of-pathogenicity, likely-benign |
Downstream transcript variant, intron variant, genic downstream transcript variant |
rs763469132 |
TTC>- |
Conflicting-interpretations-of-pathogenicity |
Downstream transcript variant, coding sequence variant, inframe deletion, genic downstream transcript variant, intron variant |
rs886041310 |
T>A,G |
Likely-pathogenic, uncertain-significance |
Missense variant, coding sequence variant |
rs1057519806 |
T>C,G |
Pathogenic, likely-pathogenic, uncertain-significance |
Coding sequence variant, missense variant |
rs1057519807 |
A>T |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs1057519808 |
T>G |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs1057519809 |
G>A,C |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs1057519810 |
C>A,T |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs1057519910 |
A>C,T |
Pathogenic, likely-pathogenic |
Coding sequence variant, missense variant |
rs1114167351 |
ATC>- |
Pathogenic |
Coding sequence variant, inframe deletion |
rs1135401787 |
A>C,G |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs1599307313 |
ACCTTG>- |
Likely-pathogenic |
Coding sequence variant, inframe deletion |
|
miRNAmiRNA information provided by mirtarbase database.
|
|
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
GO ID |
Ontology |
Definition |
Evidence |
Reference |
GO:0000165 |
Process |
MAPK cascade |
TAS |
|
GO:0000187 |
Process |
Activation of MAPK activity |
IBA |
21873635 |
GO:0000187 |
Process |
Activation of MAPK activity |
TAS |
19565474 |
GO:0004674 |
Function |
Protein serine/threonine kinase activity |
TAS |
|
GO:0004708 |
Function |
MAP kinase kinase activity |
IBA |
21873635 |
GO:0004708 |
Function |
MAP kinase kinase activity |
IDA |
8388392 |
GO:0004712 |
Function |
Protein serine/threonine/tyrosine kinase activity |
TAS |
19565474 |
GO:0004713 |
Function |
Protein tyrosine kinase activity |
IEA |
|
GO:0005078 |
Function |
MAP-kinase scaffold activity |
IMP |
29433126 |
GO:0005515 |
Function |
Protein binding |
IPI |
11909642, 17979178, 21615688, 21988832, 24746704, 25416956, 25600339, 25852190, 27086506, 28514442, 29433126, 31980649, 32296183, 32814053 |
GO:0005524 |
Function |
ATP binding |
IEA |
|
GO:0005576 |
Component |
Extracellular region |
NAS |
8388392 |
GO:0005634 |
Component |
Nucleus |
TAS |
19565474 |
GO:0005739 |
Component |
Mitochondrion |
TAS |
19565474 |
GO:0005769 |
Component |
Early endosome |
TAS |
19565474 |
GO:0005770 |
Component |
Late endosome |
TAS |
19565474 |
GO:0005778 |
Component |
Peroxisomal membrane |
HDA |
21525035 |
GO:0005783 |
Component |
Endoplasmic reticulum |
IDA |
21615688 |
GO:0005794 |
Component |
Golgi apparatus |
IDA |
21615688 |
GO:0005794 |
Component |
Golgi apparatus |
TAS |
19565474 |
GO:0005829 |
Component |
Cytosol |
TAS |
19565474 |
GO:0005874 |
Component |
Microtubule |
IDA |
21615688 |
GO:0005911 |
Component |
Cell-cell junction |
IDA |
21615688 |
GO:0005925 |
Component |
Focal adhesion |
TAS |
19565474 |
GO:0009898 |
Component |
Cytoplasmic side of plasma membrane |
IDA |
21615688 |
GO:0010629 |
Process |
Negative regulation of gene expression |
IGI |
23626836 |
GO:0018108 |
Process |
Peptidyl-tyrosine phosphorylation |
IEA |
|
GO:0030165 |
Function |
PDZ domain binding |
IDA |
21615688 |
GO:0032872 |
Process |
Regulation of stress-activated MAPK cascade |
TAS |
19565474 |
GO:0036289 |
Process |
Peptidyl-serine autophosphorylation |
IDA |
8388392 |
GO:0043539 |
Function |
Protein serine/threonine kinase activator activity |
IDA |
8388392 |
GO:0045893 |
Process |
Positive regulation of transcription, DNA-templated |
IMP |
24375836 |
GO:0046872 |
Function |
Metal ion binding |
IEA |
|
GO:0048471 |
Component |
Perinuclear region of cytoplasm |
IDA |
21615688 |
GO:0070371 |
Process |
ERK1 and ERK2 cascade |
IMP |
24375836 |
GO:0070371 |
Process |
ERK1 and ERK2 cascade |
TAS |
|
GO:0071902 |
Process |
Positive regulation of protein serine/threonine kinase activity |
IDA |
8388392 |
GO:0090170 |
Process |
Regulation of Golgi inheritance |
TAS |
19565474 |
GO:0097110 |
Function |
Scaffold protein binding |
IPI |
10409742, 21615688 |
GO:1903800 |
Process |
Positive regulation of production of miRNAs involved in gene silencing by miRNA |
IMP |
24375836 |
GO:2000641 |
Process |
Regulation of early endosome to late endosome transport |
TAS |
19565474 |
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
P36507 |
Protein name |
Dual specificity mitogen-activated protein kinase kinase 2 (MAP kinase kinase 2) (MAPKK 2) (EC 2.7.12.2) (ERK activator kinase 2) (MAPK/ERK kinase 2) (MEK 2) |
Protein function |
Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Activates the ERK1 and ERK2 MAP kinases (By similarity). Activates BRAF in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases the inhibitory intramolecular interaction between KSR1 or KSR2 protein kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF dimerization and BRAF activation (PubMed:29433126). |
PDB |
1S9I
,
4H3Q
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF00069 |
Pkinase |
72 → 369 |
Protein kinase domain |
Domain |
|
Sequence |
|
Sequence length |
400 |
Interactions |
View interactions |
|
|